CA Patent

CA2780485A1 — Nasal formulations of metoclopramide

Assigned to Evoke Pharma Inc · Expires 2010-07-01 · 16y expired

What this patent protects

Nasal formulations of metoclopramide, which remain stable and/or colorless upon storage over a period of time, are provided. Also provided are methods of treating disorders treatable with metoclopramide, comprising administering the nasal solutions to patients in need thereof.

USPTO Abstract

Nasal formulations of metoclopramide, which remain stable and/or colorless upon storage over a period of time, are provided. Also provided are methods of treating disorders treatable with metoclopramide, comprising administering the nasal solutions to patients in need thereof.

Drugs covered by this patent

Patent Metadata

Patent number
CA2780485A1
Jurisdiction
CA
Classification
—
Expires
2010-07-01
Drug substance claim
No
Drug product claim
No
Assignee
Evoke Pharma Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.